About this trial
The purpose of this study is to investigate whether acute stress can precipitate congestive heart failure (CHF) exacerbation in patients with CHF.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
None
Disqualifiers
Patients who are unable to perform EMA or laboratory assessments due to cognitive, visual, language, or other disabilities will be excluded.
Patients with Class IV heart failure will also be excluded, as they are already maximally decompensated, and a ceiling/floor effect would preclude effects of stress.
Patients with conditions other than heart failure that affect PA pressures (e.g. dialysis).
Patients with physical conditions that interfere with study participation.
Trial design
Single group
Treatments tested in this trial
Mental Stress
Other interventionPatients will undergo a lab mental stress protocol, and a field protocol using ecological momentary assessment (EMA) to test the effects of psychological stress and negative emotion on PAP in HF patients.
Treatment groups
Trial outcomes
Primary outcomes
Pulmonary Artery Pressure
Pulmonary artery pressure as measured by an implanted monitor: Pulmonary artery pressure will be compared between times of stress and calm, in both the laboratory and real-life setting.
Secondary outcomes
Medication changes
Will be compared between those with highest levels of stress-triggered PA increases, and those with lower
Other outcomes
Number of participants that are hospitalized
Hospitalizations will be compared between those with highest levels of stress-triggered PA increases, and those with lower
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Yale University
Lead sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Collaborator